What are the first-line medications for an acute migraine attack?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

First-Line Medications for Acute Migraine Attack

For mild to moderate migraine attacks, NSAIDs (ibuprofen 400-800mg, naproxen sodium 500-825mg, aspirin 900-1000mg, or diclofenac potassium) are first-line treatment, while triptans are first-line for moderate to severe attacks or when NSAIDs fail. 1, 2

Stratified Treatment Approach

Mild to Moderate Attacks

  • NSAIDs are the initial choice with specific evidence-based options including: 1, 2

    • Ibuprofen 400-800mg every 6-8 hours 2
    • Naproxen sodium 500-825mg at onset, repeatable every 2-6 hours (maximum 1.5g/day) 1
    • Aspirin 900-1000mg 2
    • Diclofenac potassium 1
  • Combination therapy (acetaminophen + aspirin + caffeine) provides synergistic analgesia when NSAIDs alone are insufficient 1

Moderate to Severe Attacks

  • Triptans are first-line for moderate-severe migraine with seven evidence-based options: 1, 2, 3

    • Sumatriptan 25-100mg orally (or 6mg subcutaneous for fastest effect) 2
    • Rizatriptan 1, 3
    • Eletriptan 3
    • Zolmitriptan 1, 3
    • Naratriptan 1, 3
    • Almotriptan 3
    • Frovatriptan 3
  • Subcutaneous sumatriptan 6mg provides the highest efficacy (59% pain-free at 2 hours) with fastest onset at 15 minutes, though with higher adverse event rates 1

Route Selection Based on Symptoms

When Nausea/Vomiting Present

  • Choose non-oral routes as gastroparesis impairs oral medication absorption: 1, 2

    • Subcutaneous sumatriptan 6mg 1
    • Intranasal sumatriptan 5-20mg or zolmitriptan 1, 4
    • Rectal sumatriptan 4
  • Add antiemetics for dual benefit (treat nausea AND provide synergistic analgesia): 1

    • Metoclopramide 10mg IV/oral 1
    • Prochlorperazine 10mg IV/25mg oral 1

Intravenous Options for Severe Attacks

  • IV metoclopramide 10mg + IV ketorolac 30mg is the recommended first-line IV combination for severe migraine requiring parenteral treatment 1

  • IV prochlorperazine 10mg is equally effective to metoclopramide with comparable efficacy 1

  • Intranasal or IV dihydroergotamine (DHE) has good evidence as monotherapy for acute attacks 1, 5

Critical Timing and Frequency Considerations

  • Administer treatment as early as possible during the attack while pain is still mild to maximize efficacy 1, 2

  • Triptans work best when taken early but NOT during aura phase 2

  • Limit acute medication use to no more than 2 days per week to prevent medication-overuse headache, which paradoxically increases headache frequency and can lead to daily headaches 1, 2

Contraindications and Safety

Triptan Contraindications (Critical to Screen)

  • Do not use triptans in patients with: 6

    • Ischemic heart disease or previous myocardial infarction 6
    • Uncontrolled hypertension 1, 2
    • Basilar or hemiplegic migraine 2
    • History of stroke or TIA 1
    • Prinzmetal's angina 6
  • Cardiovascular risk assessment required for triptan-naive patients with multiple CV risk factors (age, diabetes, hypertension, smoking, obesity, strong family history of CAD) before first dose 6

NSAID Precautions

  • Avoid NSAIDs in: 1
    • Renal impairment (CrCl <30 mL/min) 1
    • Active GI bleeding or history of GI bleeding 1
    • Aspirin/NSAID-induced asthma 1

Medications to Avoid

  • Opioids should be reserved only for last-line use when other medications cannot be used, sedation is not a concern, and abuse risk has been addressed—they lead to dependency, rebound headaches, and loss of efficacy 1, 5, 3

  • Butalbital-containing compounds should similarly be avoided except as rescue therapy for refractory attacks 1

When to Escalate to Preventive Therapy

  • Initiate preventive therapy if: 1
    • Two or more attacks per month with ≥3 days of disability 1
    • Using acute medications more than twice weekly 1
    • Contraindications to acute treatments 1
    • Failure of acute treatments despite optimization 1

References

Guideline

Acute Headache Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Migraine Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Acute Migraine Treatment.

Continuum (Minneapolis, Minn.), 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.